Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Abdulaziz M. Bin Rsheed"'
Autor:
Ayla M. Tourkmani, Turki J. Alharbi, Abdulaziz M. Bin Rsheed, Azzam F. Alotaibi, Mohammed S. Aleissa, Sultan Alotaibi, Amal S. Almutairi, Jancy Thomson, Ahlam S. Alshahrani, Hadil S. Alroyli, Hend M. Almutairi, Mashael A. Aladwani, Eman R. Alsheheri, Hyfaa Salaheldin Sati, Budur Aljuaid, Abdulaziz S. Algarzai, Abood Alabood, Reuof A. Bushnag, Wala Ghabban, Muhammed Albaik, Salah Aldahan, Dalia Redda, Ahmed Almalki, Noura Almousa, Mohammed Aljehani, Alian A. Alrasheedy
Publikováno v:
Telemedicine Reports, Vol 5, Iss 1, Pp 46-57 (2024)
Background: Patients with uncontrolled type 2 diabetes mellitus (T2DM) require close follow-up, support, and education to achieve glycemic control, especially during the initiation or intensification of insulin therapy and self-care management. This
Externí odkaz:
https://doaj.org/article/5f4fc19cd9474cf5b34fba4dfa666159
Autor:
Manal Faleh AlMutairi, Ayla M. Tourkmani, Alian A. Alrasheedy, Turki J. ALHarbi, Abdulaziz M. Bin Rsheed, Mohammed ALjehani, Yazed AlRuthia
Publikováno v:
Therapeutic Advances in Chronic Disease, Vol 12 (2021)
Background and aim: Telemedicine could be used to provide diabetes care with positive clinical outcomes. Consequently, this study evaluated the cost-effectiveness of telemedicine for patients with uncontrolled type 2 diabetes mellitus (i.e. HbA1c >9)
Externí odkaz:
https://doaj.org/article/8d391465a90a4c298ba1cd11310578b9
Autor:
Hassan A. Alsugair, Ibrahim F. Alshugair, Turki J. Alharbi, Abdulaziz M. Bin Rsheed, Ayla M. Tourkmani, Wedad Al-Madani
Publikováno v:
Healthcare, Vol 9, Iss 9, p 1125 (2021)
Introduction: Glucagon-like peptide 1 receptor agonist (GLP-1 RA) is a class of hypoglycemic medications. Semaglutide once-weekly (QW) and liraglutide once-daily (OD) significantly improved glycemic control compared to placebo. To date, no long-term
Externí odkaz:
https://doaj.org/article/4ec7666e00674c39ba63b249d014bc4d
Autor:
Yasser A Albarkah, Ayla M Tourkmani, Abdulaziz M Bin Rsheed, Turki J Al Harbi, Yasser A Ebeid, Reuof A Bushnag
Publikováno v:
Journal of Family Medicine and Primary Care, Vol 8, Iss 6, Pp 1919-1924 (2019)
Context: Available therapies for type 2 diabetes mellitus (T2DM) do not adequately control glycemia in the long term as they do not address the issue of declining beta cell function and do not impact positively on weight or cardiovascular concerns as
Externí odkaz:
https://doaj.org/article/30d01f16829040b480fdde8d8cbab147
Autor:
Turki J Alharbi, Ayla M Tourkmani, Osama Abdelhay, Hesham I Alkhashan, Abdulrahman K Al-Asmari, Abdulaziz M Bin Rsheed, Sarah N Abuhaimed, Najeebuddin Mohammed, Abdulrhman N AlRasheed, Nouf G AlHarbi
Publikováno v:
PLoS ONE, Vol 13, Iss 10, p e0204420 (2018)
AIMS:To compare the prevalence of vitamin B12 deficiency and peripheral neuropathy between two groups of type 2 diabetes mellitus (T2DM) patients treated with or without metformin, and to determine factors associated with vitamin B12 deficiency thera
Externí odkaz:
https://doaj.org/article/a7fd1a86ac39442bae8d752e82d20573